Tilray (TLRY) - Get Report shares jumped on Tuesday after Cowen & Co. affirmed its outperform rating on the cannabis producer and distributor but sharply lowered its price target to $60 a share from $150.
The Nanaimo, British Columbia, company's stock rose $4.43, or 17%, to $30.10 Tuesday, its best one-day performance since Jan. 11 when it rose 19.4%. The stock traded as high as $300 a share a bit less than a year ago.
Tilray is the cannabis company hit hardest by weak industry supply, since it was overly reliant on third parties, analyst Vivien Azer said in a Sept. 3 report. The company is addressing the issue by expanding its current facilities and through acquisitions.
Most recently, Tilray said last week it would pay up to C$110 million for the Alberta cannabis retailer Four20.
The company is now well-positioned for multiple entry points into the U.S. And as the company builds on its Portugal license, "we look for international to become a key piece of the growth story," the analyst wrote.
Tilray led gainers in the cannabis sector Tuesday. Among notable cannabis stocks, 11 rose while 4 fell.
The Alternative Harvest ETF (MJ) - Get Report rose 64 cents, or 2.67%, to $24.65. The AdvisorShares Pure Cannabis ETF (YOLO) - Get Report rose 49 cents, or 2.79%, to $18.06. The Horizons Marijuana Life Sciences ETF (HMLSF) rose 37.53 cents, or 3.54%, to $10.98.
Large cap stocks with notable cannabis initiatives were mixed. Shares of Molson Coors Brewing Company (TAP) - Get Report rose $1.03, or 2.01%, to $52.39. The company is working to develop beers infused with cannabis for the Canadian market.